Perevozchikov et al., Human APO A-1 cDNA Gene Expression in Transgenic Rabbits: Modeling of the Neurological Syndrome of Human Tangier Disease, Biological Abstracts, 96,3, Abst. No. 28308, (1993). |
Chowdhury et al., Long-Term Improvement of Hypercholesterolemia After ex Vivo Gene Therapy in LDLR-Deficient Rabbits, Science, 254, 1802-1804, (1991). |
Schultz et al., Protein Composition Determines the Anti-Atherogenic Properties of HDL in Transgenic Mice, Nature, 365, 6448, 762-764, (1993). |
Latta et al., Human Alpolipoprotein AII Can Be Overproduced as A Recombinant Protein From E-coli, Circulation, 86, 4, 133, (1992). |
Duverger et al., Functional Characterization of Human Recombinant Apolipoprotein AIV Produced in Escherichia coli, Euro. Journal of Biochemistry, 201, 2, 373-383, (1991). |
Perevozchikov et al. Expression of Human Apolipoprotein A-1 gene cDNA in Transgenic Rabbits: Modeling of the Neurologic Syndrome of Human Tangier Disease. Molecular Biology, vol. 27, No. 1, pp. 6-14, Jan. 2, 1993. |
Hoeg et al, Development of transgenic watanabe heritable hyperlipidemic rabbits expressing human apoA-1. Circulation, vol. 88, No. 4, part 2, #0010, Oct. 1993. |